Skip to Main Content
CKG
Home
Home
Home
TKG
Paper Details
Breadcrumb
Paper Details
Paper Title
Inhibition of mevalonate metabolism by statins augments the immunoregulatory phenotype of vascular endothelial cells and inhibits the costimulation of CD4<sup>+</sup> T cells.
PubMed
Paper Journal Title
Am J Transplant
Paper Citation Count
3
Paper Publication Year
2022
Bio Mention
-, CD4, CD4+, CD4+ T cells, CD45RO, CD45RO+ CD4+ T cell, EC, GITR-L, Galectin-3, Galectin-9, IFN, IL-2, IL-6, L-mevalonate, LGALS3, LGALS9, OX40-L, RNA, TNFSF18, TNFSF4, cholesterol, endothelial cells, immunoregulatory genes, mevalonate, pro-inflammatory genes, simvastatin, statin, statins, transcriptomic, treated, vascular endothelial cells, vehicle-treated EC
Mesh Descriptor
CD4-Positive T-Lymphocytes, Cells, Cultured, Endothelial Cells, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Mevalonic Acid, Phenotype, Simvastatin, T-Lymphocytes
Go
Actions
Author Name
Affiliation
Timna Agur
Boston Children's Hospital
Timna Agur
Harvard Medical School
Johannes Wedel
Boston Children's Hospital
Johannes Wedel
Harvard Medical School
Sayantan Bose
Boston Children's Hospital
Sayantan Bose
Harvard Medical School
A G Pramoda Sahankumari
Boston Children's Hospital
Daniel Goodman
Boston Children's Hospital
Sek Won Kong
Boston Children's Hospital
Sek Won Kong
Harvard Medical School
Chandra C Ghosh
Boston Children's Hospital
Chandra C Ghosh
Harvard Medical School
David M Briscoe
Boston Children's Hospital
David M Briscoe
Harvard Medical School
1 - 14
Column Actions
Search
Datasets